Think “longevity” and a particular type of person comes to mind. A biohacker, covered in smart devices tracking their every move. Probably a man. Possibly specifically Bryan Johnson, the American tech entrepreneur who has developed a $2 million-a-year protocol in pursuit of his one goal: “Don’t die.”
It’s this association that has led Dr Sabine Donnai, founder and chief executive of private health clinic Viavi, to dislike the term “longevity”— even though that’s exactly what her practice focuses on. “For me, longevity is about prevention, in the main, of chronic diseases and functional decline,” she tells me in a room at Viavi’s clinic, which occupies one of the grand terraces on Devonshire Place, near Harley Street. Her take may not be as sexy, but it does sound eminently reasonable. She likes to frame it as “healthy longevity”— “because what’s the point of living long unless you have all your functionality there?”
Donnai’s interest in longevity began when she qualified as a doctor in her native Belgium and felt disillusioned with how much medical practice focused on matching symptoms of ill health with diagnoses and then treatments. Wouldn’t it make more sense to keep people healthy in the first place? She travelled to different countries to learn about approaches to healthcare, and moved to the UK 28 years ago. She held various roles, including at Bupa and Nuffield Health, before setting up Viavi in 2009, offering bespoke plans to live healthier for longer. Her elite client list includes the likes of Chris Rokos, founder of Rokos Capital Management, and Edmund Reed, managing partner of law firm Travers Smith.
Bespoke treatment
Bu hikaye The London Standard dergisinin December 05, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye The London Standard dergisinin December 05, 2024 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
This industry can be snakey and gross
Teddy Swims on how tackling his demons turned him into a megastar ready to take this weekend's Brits by storm
Our obsession with prizes makes fools of us all
As the Oscars roll into town again, this is why I despair of the whole charade
Hotpants are the hot ticket for the fashion pack as they hit the town
To quote Daniel Cleaver in Bridget Jones, skirt was very much off sick this London Fashion Week.
Al is on the march in Hollywood — but is there still a plot twist to come?
It's uprooting the way films are made (and viewed) but can it ever produce a classic, asks WILLIAM HOSIE
Seven ways to get the LFW look
Haute hoodies, sharp ties and queenly quilting
Welcome to Wandsworth
It's this year's borough of culture — but loyal locals already know it's the place to be
The problem with mummy and daddy's money
London is now an inheritocracy. It's both golden ticket and gilded cage
The hottest new talent at Somerset House, death and glory at Pitzhanger—and Jeff Koons's country cousin
Collect 2025 Somerset House
Shine on! London's top hairdressers share their secrets for glossy locks
A few summers ago, I tried to grow out my bob and failed miserably, because I didn't just want length, I wanted hair that was an event, a mane, hair that swished. For that, you need not only length but heft, and heft relies heavily on health.
From $6bn to $100m in four years-how did it all unravel for DNA pioneer 23andMe?
The DNA analysis firm 23andMe is a company on the ropes. The one-time leader of the market - valued at $6 billion in 2021 - is now worth less than $100 million, a 99 per cent drop that makes Labour's autumn Budget look like a roaring success.
